All News about Evolus Inc![]() ![]() ![]() ![]() ![]() From Evolus
Via Business Wire
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() From Evolus, Inc.
Via Business Wire
![]()
Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 08, 2023
From Evolus
Via Business Wire
![]()
Evolus to Participate in the Barclays Global Healthcare Conference
February 28, 2023
From Evolus
Via Business Wire
![]()
Evolus Initiates Nuceiva® Launch in Germany and Austria
February 27, 2023
From Evolus, Inc.
Via Business Wire
![]() ![]() ![]()
Evolus to Report Fourth Quarter and Year End 2022 Results and Provide Business Update
February 22, 2023
From Evolus
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() From Evolus
Via Business Wire
![]() ![]()
Evolus Receives Regulatory Approval for Nuceiva® in Australia
January 23, 2023
From Evolus
Via Business Wire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|